China’s WuXi Biologics Unveils TrueSite TI™, A Groundbreaking Platform Set to Redefine Biopharmaceutical Development
In the global race to develop next-generation medicines, speed, precision, and reliability are paramount. Continuing to establish its role at the forefront of China’s innovation in the life sciences, WuXi Biologics has launched TrueSite TI™, a state-of-the-art cell line platform poised to transform the landscape of biopharmaceutical development. This fourth-generation technology isn’t just an incremental […]